BioMerieux (XPAR:BIM) Accounts Payable : €265 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is BioMerieux Accounts Payable?

BioMerieux's Accounts Payable for the quarter that ended in Dec. 2023 was €265 Mil.

BioMerieux's quarterly Accounts Payable declined from Dec. 2022 (€269 Mil) to Jun. 2023 (€244 Mil) but then increased from Jun. 2023 (€244 Mil) to Dec. 2023 (€265 Mil).

BioMerieux's annual Accounts Payable increased from Dec. 2021 (€240 Mil) to Dec. 2022 (€269 Mil) but then declined from Dec. 2022 (€269 Mil) to Dec. 2023 (€265 Mil).

BioMerieux Accounts Payable Historical Data

The historical data trend for BioMerieux's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Accounts Payable Chart

BioMerieux Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

211.90

207.10

239.50

269.40

265.10

BioMerieux Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															239.50	243.40	269.40	243.50	265.10

BioMerieux Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

BioMerieux Accounts Payable Related Terms

Thank you for viewing the detailed overview of BioMerieux's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BioMerieux (XPAR:BIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (XPAR:BIM) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

BMXMF:USA BIMp:UK 0RUG:UK EYWN:Germany BIM:Austria

Address

Marcy l’Etoile, Lyon, FRA, 69280

Website

http://www.biomerieux.com

BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.

BioMerieux (XPAR:BIM) Headlines

No Headlines